Agile Therapeutics | AGRX - Beneficio Operativo



Beneficio Operativo Cambio Fecha
Adma Biologics USD 51.01M 8.21M 2025-09
Alterity Therapeutics Limited AUD -7.77M 2.99M 2023-06
Bayer EUR 1.11B 1.65B 2025-12
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Cassava Sciences USD -11.86M 2.23M 2025-09
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD -7.89M 540K 2025-09
CSL USD 2.64B 1.97B 2025-12
Grifols EUR 411.56M 15.51M 2025-09
J&J USD 5.59B 1.81B 2025-12
Merck USD 6.24B 318M 2025-12
Pacira USD 3.19M 9.96M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
TherapeuticsMD USD -1.18M 40K 2024-06